Viatris, Inc. (VTRS)
11.46
-0.20
(-1.72%)
USD |
NASDAQ |
Dec 16, 16:00
11.46
0.00 (0.00%)
After-Hours: 20:00
Viatris Research and Development Expense (Annual): 802.90M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Amgen, Inc. | 5.676B |
| BioCryst Pharmaceuticals, Inc. | 173.39M |
| Indivior PLC | 107.00M |
| Moderna, Inc. | 4.354B |